Coave Therapeutics
Developer of genetic medicine technologies intended to address neurodegenerative diseases through targeted therapies. The company's platform is useful for delivering low doses of therapeutic genes lik...
Valuation
$0
Share Price
N/A
Total Raised
$80.8M
Last Round
N/A